These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20553848)

  • 1. Proteome profiling of mouse embryonic stem cells to define markers for cell differentiation and embryotoxicity.
    Osman AM; van Dartel DA; Zwart E; Blokland M; Pennings JL; Piersma AH
    Reprod Toxicol; 2010 Sep; 30(2):322-32. PubMed ID: 20553848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early gene expression changes during embryonic stem cell differentiation into cardiomyocytes and their modulation by monobutyl phthalate.
    van Dartel DA; Pennings JL; Hendriksen PJ; van Schooten FJ; Piersma AH
    Reprod Toxicol; 2009 Apr; 27(2):93-102. PubMed ID: 19162170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomics-based identification of developmental toxicants through their interference with cardiomyocyte differentiation of embryonic stem cells.
    van Dartel DA; Pennings JL; van Schooten FJ; Piersma AH
    Toxicol Appl Pharmacol; 2010 Mar; 243(3):420-8. PubMed ID: 20036270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disentangling cellular proliferation and differentiation in the embryonic stem cell test, and its impact on the experimental protocol.
    van Dartel DA; Zeijen NJ; de la Fonteyne LJ; van Schooten FJ; Piersma AH
    Reprod Toxicol; 2009 Sep; 28(2):254-61. PubMed ID: 19442486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose response analysis of monophthalates in the murine embryonic stem cell test assessed by cardiomyocyte differentiation and gene expression.
    Schulpen SH; Robinson JF; Pennings JL; van Dartel DA; Piersma AH
    Reprod Toxicol; 2013 Jan; 35():81-8. PubMed ID: 22813628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of developmental toxicant identification using gene expression profiling in embryonic stem cell differentiation cultures.
    van Dartel DA; Pennings JL; de la Fonteyne LJ; Brauers KJ; Claessen S; van Delft JH; Kleinjans JC; Piersma AH
    Toxicol Sci; 2011 Jan; 119(1):126-34. PubMed ID: 20935163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration-dependent gene expression responses to flusilazole in embryonic stem cell differentiation cultures.
    van Dartel DA; Pennings JL; de la Fonteyne LJ; Brauers KJ; Claessen S; van Delft JH; Kleinjans JC; Piersma AH
    Toxicol Appl Pharmacol; 2011 Mar; 251(2):110-8. PubMed ID: 21192963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow stromal cells as an inducer for cardiomyocyte differentiation from mouse embryonic stem cells.
    Yue F; Johkura K; Tomotsune D; Shirasawa S; Yokoyama T; Nagai M; Sasaki K
    Ann Anat; 2010 Sep; 192(5):314-21. PubMed ID: 20801009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of murine embryonic stem cell gene expression profiles with functional measures of pluripotency.
    Palmqvist L; Glover CH; Hsu L; Lu M; Bossen B; Piret JM; Humphries RK; Helgason CD
    Stem Cells; 2005 May; 23(5):663-80. PubMed ID: 15849174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative proteomic analysis of mouse embryonic stem cells and neonatal-derived cardiomyocytes.
    Baharvand H; Hajheidari M; Zonouzi R; Ashtiani SK; Hosseinkhani S; Salekdeh GH
    Biochem Biophys Res Commun; 2006 Oct; 349(3):1041-9. PubMed ID: 16973132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of novel high-throughput embryonic stem cell tests with new molecular markers for screening embryotoxic chemicals in vitro.
    Suzuki N; Ando S; Yamashita N; Horie N; Saito K
    Toxicol Sci; 2011 Dec; 124(2):460-71. PubMed ID: 21964422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative proteome and transcriptome analyses of embryonic stem cells during embryoid body-based differentiation.
    Fathi A; Pakzad M; Taei A; Brink TC; Pirhaji L; Ruiz G; Sharif Tabe Bordbar M; Gourabi H; Adjaye J; Baharvand H; Salekdeh GH
    Proteomics; 2009 Nov; 9(21):4859-70. PubMed ID: 19862760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embryotoxicity hazard assessment of methylmercury and chromium using embryonic stem cells.
    Stummann TC; Hareng L; Bremer S
    Toxicology; 2007 Dec; 242(1-3):130-43. PubMed ID: 17980949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The embryonic stem cell test combined with toxicogenomics as an alternative testing model for the assessment of developmental toxicity.
    van Dartel DA; Piersma AH
    Reprod Toxicol; 2011 Sep; 32(2):235-44. PubMed ID: 21575713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embryotoxicant-specific transcriptomic responses in rat postimplantation whole-embryo culture.
    Robinson JF; van Beelen VA; Verhoef A; Renkens MF; Luijten M; van Herwijnen MH; Westerman A; Pennings JL; Piersma AH
    Toxicol Sci; 2010 Dec; 118(2):675-85. PubMed ID: 20864626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF2 signaling in mouse embryonic fibroblasts is crucial for self-renewal of embryonic stem cells.
    Diecke S; Quiroga-Negreira A; Redmer T; Besser D
    Cells Tissues Organs; 2008; 188(1-2):52-61. PubMed ID: 18334814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency ranking of valproic acid analogues as to inhibition of cardiac differentiation of embryonic stem cells in comparison to their in vivo embryotoxicity.
    de Jong E; Doedée AM; Reis-Fernandes MA; Nau H; Piersma AH
    Reprod Toxicol; 2011 May; 31(4):375-82. PubMed ID: 21115111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of mouse embryonic stem cell differentiation into the pancreatic lineage in vitro by transcriptional profiling, quantitative RT-PCR and immunocytochemistry.
    Rolletschek A; Schroeder IS; Schulz H; Hummel O; Huebner N; Wobus AM
    Int J Dev Biol; 2010; 54(1):41-54. PubMed ID: 19876843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced differentiation of human embryonic stem cells to mesenchymal progenitors by inhibition of TGF-beta/activin/nodal signaling using SB-431542.
    Mahmood A; Harkness L; Schrøder HD; Abdallah BM; Kassem M
    J Bone Miner Res; 2010 Jun; 25(6):1216-33. PubMed ID: 20200949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected common mechanistic pathways for embryotoxicity of warfarin and lovastatin.
    Groebe K; Hayess K; Klemm-Manns M; Schwall G; Wozny W; Steemans M; Peters AK; Sastri C; Jaeckel P; Stegmann W; Zengerling H; Schöpf R; Poznanovic S; Stummann TC; Seiler A; Spielmann H; Schrattenholz A
    Reprod Toxicol; 2010 Aug; 30(1):121-30. PubMed ID: 20493250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.